All News

Hypertension, Albuminuria Common Among Pediatric Type 2 Diabetes

May 08, 2021

A systematic review and meta-analysis of studies examining pediatric type 2 diabetes indicate hypertension or albuminuria was present among approximately 20% of children with type 2 diabetes.

Many Adults with Hypertension Also Taking Medications that Raise Blood Pressure

May 07, 2021

Data from an analysis of NHANES suggest nearly 1-in-5 adults with hypertension were also taking medication that may increase blood pressure.

Bariatric Surgery Linked to Lower Risk of Cardiovascular Death, Adverse Events in Patients with T2D

May 06, 2021

An analysis of claims data from more than 7k patients suggests patients with severe obesity and type 2 diabetes who underwent bariatric surgery experienced a 68% reduction in cardiac mortality and 34% reduction in cardiac events compared against standard medical management.

AHA Provides Overview of CV Risk Associated with Hormone Therapies Used in Breast, Prostate Cancer Treatment

May 05, 2021

The AHA has released a scientific statement aimed at outlining the current knowledge base related to risk of cardiovascular disease associated with hormonal therapies used in the treatment of breast and prostate cancer.

Comparing Days Alive and Out of Hospital with Invasive vs Conservative Management in ISCHEMIA

May 05, 2021

New data from an analysis of the ISCHEMIA trial is providing insight into the days alive out of hospital with an initial invasive or conservative approach to the management of stable ischemic heart disease.

Do N-of-1 Studies Prove Statin Muscle Complaints are Bogus?

May 04, 2021

Dr. Paul Thompson reflects on the results of recent N-of-1 studies examining the effects of statin therapy on muscle pain and offers his perspective on the conclusions drawn by these trials.

AHA/ASA Release Guidance for Treatment of COVID-19 Vaccine-Related Clotting, Low Platelet Counts

May 03, 2021

The American Heart Association and American Stroke Association have released a special report related to the treatment of blood clots or low platelet counts related to the COVID-19 vaccine, which has garnered mass amounts of attention despite being a rare complication.

Follow-up Results for Harmony TPV System Demonstrate Efficacy at 1-Year

May 02, 2021

Results of 1-year follow-up from the Harmony TPV Clinical trial provide insight into the safety and efficacy of the recently approved Harmony TPV system in patients with congenital heart disease and severe pulmonary regurgitation.

Dapagliflozin (Farxiga) Receives Historic FDA Approval for Chronic Kidney Disease

April 30, 2021

The US FDA announced dapagliflozin (Farxiga) received approval for reducing the risk of kidney function decline, kidney failure, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression in a statement on April 30.

Presentations for Acute MIs Dropped Drastically During Peak of COVID-19 Pandemic

April 30, 2021

An analysis of data from NYU Langone provides perspective into the rapid decline of emergency department presentations for acute myocardial infarction that occurred during the peak of the COVID-19 pandemic.